BackCynata Therapeutics Limited Overview

Cynata Therapeutics Limited Intangible Assets

Latest intangible assets for CYYNF: $230K.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$234635.00
↓ 87.31% YoYΔ $-1.61M vs prior year quarter

Peer trimmed avg / median

Loading

Cynata Therapeutics Limited Intangible Assets History

Loading

Cynata Therapeutics Limited vs. peers: Intangible Assets Comparison

Loading

Cynata Therapeutics Limited Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cynata Therapeutics Limited (CYYNF) FAQ

As of the most recent data (June 2026), CYYNF shows a intangible assets of $230K. That compares with $1.8M in the prior-year period — down 87.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYYNF's intangible assets is now $230K (was $1.8M) — a 87.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cynata Therapeutics Limited is outperforming or lagging.

Tracking CYYNF's intangible assets over time shows whether Cynata Therapeutics Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $230K That compares with $1.8M in the prior-year period — down 87.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Cynata Therapeutics Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $230K) with ownership activity and broader fundamentals.

Cynata Therapeutics Limited's intangible assets is $230K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.